Mossman Associates Inc.

CLIAWAIVED.com signs distribution deal with Mossman Associates, and licenses global co-marketing rights to Mossman’s rapid nicotine testing technology

2011-10-06T10:32:00.000-04:00

CLIAWAIVED.com announced the execution of an agreement for the exclusive US distribution and global co-marketing rights to Mossman’s NicCheck, rapid nicotine testing technology.

San Diego, CA, October 1, 2011

CLIAWAIVED.COM, Inc., the leading internet based, multi-line distributor of POC (point-of- care) CLIA waived Diagnostic tests in the US and Mossman Associates Inc., a leading diagnostic test manufacturer, today announced the execution of an agreement for the exclusive US distribution rights along with global co-marketing rights to Mossman’s NicCheck products and rapid nicotine testing technology.

CLIAwaived.com has agreed to pay Mossman Associates, Inc. an undisclosed fee for exclusive US license rights of NicCheck branded products along with the right to sell Mossman’s rapid nicotine testing products globally under CLIAwaived’s private label brand. Mossman’s NicCheck products are an ideal fit for the CLIAwaived.com portfolio of diagnostic products and will be marketed both in the US and globally with dozens of other rapid diagnostics. Specifically, this addition is strategically aimed at serving the growth-oriented point-of-care diagnostic markets including the increasingly growing need for waived tests in the physician office lab, addiction treatment and clinical research markets. At present, NicCheck is the only FDA Cleared and CLIA waived semi-quantitative instant nicotine test on the market that is CLIA compliant for these market segments.

Donald Mossman, President of Mossman Associates, Inc. said “we are pleased that CLIAWAIVED.COM has opted to become our exclusive distributor in the USA. Their position as the premier site for ordering CLIA waived test kits is a natural fit for our NicCheck product. Their site will offer our existing customers an internet option not currently available to them while exposing our product to a much larger customer base.”

Tim Drapeau, President of CLIAwaived, Inc. said, " I am delighted that Mossman Associates has chosen CLIAwaived.com to sell, distribute and market their NicCheck rapid nicotine testing products exclusively in the US POC market. As a company specializing in distributing CLIA compliant devices we believe the NicCheck product line will dominate our target markets and strengthen our position and portfolio of CLIA waived rapid diagnostics.”

About CLIAWAIVED.COM

CLIAWAIVED.COM, is a leading, Internet based, multi-line distributor of CLIA Waived, point-of-care diagnostic products to the healthcare industry. CLIAWAIVED’s portfolio of distributed products includes rapid diagnostics for early diagnosis and treatment of various diseases and conditions.

About Mossman Associates, Inc.

Mossman Associates, Inc. is a manufacturer and distributor of medical diagnostic test kits whose portfolio of products includes rapid onsite products for detection and screening of drugs of abuse, nicotine and alcohol as well as a serological test for tuberculosis.
Contact: CLIAWAIVED.COM
Mr. Tim Drapeau, President
CLIAwaived,Inc.
11578 Sorrento Valley Road
San Diego, CA 92121
www.cliawaived.com

OR

Mossman Associates, Inc.
Mr. Donald Mossman
9 Village Circle
Milford, MA 01757
www.mossmanassociates.com
508-488-6169

Smoking Cessation Campaigns Around The World Using NicCheck to Confirm Success Once Again

2011-06-23T14:24:00.000-04:00

Milford, Massachusetts; 6/23/2011 - Mossman Associates Inc. is pleased to announce that our NicCheck is being used once again within a number of Smoking Cessation Campaigns around the world.

Campaigns within the Lung Association of Manitoba, Canada as well as campaigns in Taiwan, Montreal, Canada and the University of Minnesota are once again using the NicCheck test to confirm success. This represents consecutive years that the test has been part of these well established campaigns.

Donald Mossman, President of Mossman Associates Inc. notes, "We are pleased to be able to contribute to these programs which are designed to help those people trying to quit smoking. Our NicCheck product has been shown to be effective when used to monitor a person’s nicotine consumption as they reduce their nicotine dependence. Our test is simple and because it is a rapid visual test, it is conducive to being run in the field, lending itself nicely to smoking cessation programs as well as spot checks and remote health locations”.

For more information contact:

Donald Mossman, President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
508-488-6169 (P)
don@mossmanassociates.com

NicCheck to be used within evidence based smoking cessation contests, results in time for World No Tobacco Day 2011

2011-04-01T09:24:00.000-04:00

May 31, 2011 has been set aside as World No Tobacco Day. The 31st of May each year the World Health Organization (WHO) celebrates World No Tobacco Day, highlighting the health risks associated with tobacco. The WHO uses this day to be an advocate for effective policies to reduce tobacco consumption, specifically through tobacco control messages, and to promote adherence to the WHO Framework Convention on Tobacco Control.

The WHO Framework Convention on Tobacco Control is the world’s foremost tobacco control treaty. This treaty, negotiated under the auspices of the WHO, was put in place in 2005 and to date is the most widely embraced treaty in the history of the United Nations. Currently there are 172 parties endorsing this evidence-based treaty that reaffirms the rights of all people to the highest standard of health and provides new legal dimensions for cooperation in tobacco control.

Once again, Mossman Associates’ NicCheck test has been chosen to be the evidence based test used to confirm smoking cessation in a number of Quit and Win contests around the world. Completion of these and the announcements of the contest winners should be in time to celebrate World No Tobacco Day.

“We can think of no better way to celebrate the upcoming event than to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates. He continues, “Competitions in Finland, Canada, and Taiwan should all conclude in time to celebrate this noteworthy day. We look forward to working with other countries, universities and organizations that take on these types of programs”.

About Mossman Associates, Inc.

Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.

Mossman Associates Inc Announces It Is ISO 9001 Compliant.

2010-11-17T12:46:00.000-05:00

November 17, 2010; Milford, MA. Mossman Associates Inc is proud to announce it is ISO 9001 compliant.

Mossman Associates Inc is proud to announce it is ISO 9001 compliant.

The compliance with ISO 9001 recognizes that the policies, practices and procedures of our company ensure consistent quality in the product and services we provide our clients. Compliance assures our clients can be confident that Mossman Associates Inc is dedicated to maintaining the highest efficiency and responsiveness in achieving our ultimate goal – guaranteed client satisfaction.

To maintain our compliance, Mossman Associates Inc will perform audits to ensure compliance and to assess initiatives for continued improvement. Our clients can be confident that we will continue to provide the high quality products and services they have come to expect well into the future. We believe that our decision is a proactive one that not only anticipates the demands of our clients, but also demonstrates our commitment to providing quality services to all our clients.

For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com

Website For Mossman Associates Inc Expanding

2010-08-04T18:15:00.000-04:00

The website for Mossman Associates Inc is expanding and is due to be released at the end of this month. New features will include expanded choices for nicotine diagnostics, drugs of abuse, alcohol and the addition of HIV 1&2 tests.

NicCheck (the CLIA Waived test for nicotine) and MycoDot (serological test for TB) the original products in the diagnostic test kit line are still available and will be complimented by these new additions.

An improved Contact page, Calendar page and Blog page as well as movies and downloadable articles round out the extensive improvements made to the site.

Romanian Quit &Win 2010 Challenge Concludes Smoking Cessation Screening Using NicCheck I Test Strips

2010-06-15T21:12:00.001-04:00

The Romanian Quit&Win 2010 Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation.

Tuesday June 15, 2010 Mossman Associates, Inc., announced today that the Romanian Quit & Win 2010 Smoking Cessation Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation among the potential contest winners.

Prof. Radu M. Negoescu, PhD, MPH, Head, Unit of Healthy Lifestyle Promotion of
The Institute of Public Health, has reported “Please accept our renewed thanks for giving us the possibility to validate Quit & Win 2010 Romania winners using NicCheck tests.
As usual, NicCheck did work well and helped a lot to distinguish among false and sincere competitors.

The campaign mobilized 245 participants competing for several 11 day sojourns in renown or just-opened Health (life style) Centers at Herghelia, county of Mures, and Podis, county of Bacau; such a sojourn is valued about $ 500. NicCheck testing has been applied to participants in drawing order after a successful telephonic interview of the witness and of the candidate. Testing was applied by qualified personnel from Public Health Authorities closest to candidate's residence.”

Donald Mossman, President of Mossman Associates is quoted as saying, "We are again pleased to be chosen to be involved with this important project. We have seen how our test can be used in the field, such as our involvement in the rural countryside of the Philippines, as well as by lab clinicians such as with the Canadian Quit and Win Challenge. Currently we are becoming more involved with doctors and how NicCheck can be used to better determine the amount of Nicotine Replacement Therapy (NRT) that is required for their patients. We feel strongly that the addition of NicCheck as a tool, for one’s smoking cessation efforts will improve results and help with kicking the habit ".
Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 508-488-6169 (P)
508-418-1397 (F)
contact@mossmanassociates.com

Detection of Nicotine and Its Metabolites in Urine

2010-06-05T19:04:00.000-04:00

Official Publication Of The American Academy Of Health Behavior

Amruta R. Eswara, PhD
Saraswathy V. Nochur, PhD
Donald J. Mossman

ABSTRACT: A simple strip test has been developed for the detection of nicotine and its metabolites in urine. The NicCheck® I test yields a pink color on the test strip within 30 minutes, providing a semi-quantitative measure of tobacco consumption. When tested on urine from smokers and nonsmokers, the test was determined to have an overall sensitivity and specificity of 99% when compared to an EIA for cotinine determination. The test detects both nicotine and cotinine, as well as a number of other nicotine metabolites, thus providing a more complete indication of overall tobacco consumption. Based on its simplicity, accuracy, and ease of use, the test could conceivably have several applications.

NicCheck Used To Confirm Smoking Cessation Within Quit & Win 2010 Smoking Cessation Competition

2010-03-30T17:46:00.000-04:00

NicCheck once again to be the rapid test of choice for participants within the Quit and Win contest confirming smoking cessation.

Milford, Massachusetts; 3/30/10- Mossman Associates, Inc. announced today that NicCheck is being used once again within the Quit & Win 2010 contest. Participants within this worldwide smoking cessation competition have chosen NicCheck I once again to be the rapid test they used to confirm smoking cessation.
Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again following our involvement with the annual Quit and Win contest in Canada. We have received positive feedback from such people as those at The John Tung Foundation in Taiwan, and Anti-Smoking activists in Romania, Malta and Korea.”
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com

Canadian Quit &Win 2009 Challenge Concludes Smoking Cessation Screening Using NicCheck I Test Strips

2009-05-15T18:13:00.000-04:00

The Canadian Quit&Win 2009 Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation.

Thursday May 15, 2009 Mossman Associates, Inc., announced today that the Canadian Quit & Win 2009 Smoking Cessation Challenge, a yearly smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation among the potential contest winners.

All contestants had smoked daily for at least one year and are 18 years of age or older. The contestants are required to abstain from smoking for at least four weeks, which is verified with a urine test among the potential winners. The test chosen once again is NicCheck I.

Donald Mossman, President of Mossman Associates is quoted as saying, "We are again pleased to be chosen to be involved with this important project. We have seen how our test can be used in the field, such as our involvement in the rural countryside of the Philippines, as well as by lab clinicians such as with the Canadian Quit and Win Challenge. We are now becoming more involved with doctors and how the test can be used to better determine the amount of Nicotine Replacement Therapy that is required by their patients. We feel strongly that the addition of NicCheck I as a tool, to both doctors and those trying to “kick the habit”, will improve results that are seen from anyone’s smoking cessation efforts".
Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 508-488-6169 (P)
508-418-1397 (F)
contact@mossmanassociates.com

NicCheck I (formerly from DynaGen Inc) Distributed By Physicians Sales and Services, Inc. (PSS) to Physician’s Offices

2009-01-21T18:00:00.000-05:00

NicCheck I the only rapid CLIA waived urine test for nicotine and cotinine is now available to doctor’s offices through PSS (Physicians Sales and Service, Inc.)

Wednesday January 21, 2009, Milford, MA- Mossman Associates, Inc. is pleased to announce that NicCheck is now conveniently available through PSS (Physician Sales & Service, Inc.).

Physician Sales & Service, Inc. was founded in 1983 with a mission to fulfill the inventory needs of office-based physicians by providing unique and innovative services. Based in Jacksonville, FL, PSS has grown into the country’s largest provider of medical supplies to the physician market through its commitment to fast service.

“We are happy to be able to have PSS make available our test to the numerous physician’s offices that they visit on a regular basis. The addition of all of these sales representatives is a major step forward in our efforts to get further exposure in the primary care market”, commented Donald Mossman, President of Mossman Associates, Inc.

“PSS joins others such as the on-line outlets Cliawaived.com and Testcountry.com as distributors of NicCheck, although our company can still be contacted for direct sales as we continue to ship the product worldwide”. Our test, which was originally developed at DynaGen Inc, Cambridge Massachusetts, has been used in physician’s offices since the mid 1990’s worldwide and has become an integral part of the Japanese Health Manual" further comments Don Mossman.

About Mossman Associates, Inc.
Mossman Associates, Inc is a private medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.

Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 508-488-6169 (P)
508-418-1397 (F)
contact@mossmanassociates.com

NicCheckTM Used To Confirm Smoking Cessation Within The International Quit & Win 2008 Smoking Cessation Competition

2008-09-23T18:07:00.000-04:00

NicCheck once again to be the rapid test of choice of participants within the Quit and Win contest to confirm smoking cessation

Milford, Massachusetts; 9/23/08 - Mossman Associates, Inc. announced today that NicCheck was used once again within the International Quit & Win 2008 contest. Participants within this worldwide smoking cessation competition, has chosen NicCheck I once again to be the rapid test they used to confirm smoking cessation. The program is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH).

Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit&Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years.

Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again. We have received positive feedback from such people as those at The John Tung Foundation, Taiwan, where they said “Thanks to the NicCheck Kits, we had successfully held the campaign and helped nearly 20,000 people to experience the good of quitting smoking”. Similar sentiments are expressed by Anti-Smoking activists in Malta, Canada any many other areas around the world.”

NicCheck (formerly a product of DynaGen Inc) is used worldwide to aid in smoking cessation programs, general health and surgical hospitals.
For more information contact:
Donald Mossman
President
Mossman Associates Inc
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com

NicCheck I Test (formerly from DynaGen Inc) Used By STICKK.COM For Smoking Cessation Commitments, By Confirming Individuals Smoking Status

2008-05-03T18:11:00.000-04:00

STICKK.COM, A New Website Helping With Smoking Cessation Uses NicCheck I to confirm smoking status.

Friday, March 3, 2008 Mossman Associates, Inc. announced today that they have joined with STICKK.COM to assist in a smoking cessation project. The website launched in just recently promotes healthier, happier living, by helping individuals and groups make and fulfill commitments to improve their lives. StickK.com does this by providing an easy mechanism for individuals to post financial commitments to achieve goals such as lose weight, stop smoking, look for love, train for a marathon, go green, etc.

Research by members of the stickK.com scientific advisory board, and others, shows that financial contracts like this can make individuals up to three times more likely to achieve goals such as smoking cessation and weight loss.

Donald Mossman, President of Mossman Associates is quoted as saying "We are pleased to be involved with this project and continue to be involved with smoking cessation projects around the world. Our test, NicCheck I, can be used to enable doctors or the smoker themselves to better determine the amount of Nicotine Replacement Therapy (NRT) they require. NicCheck can be used as a positive reinforcement tool during this difficult process by being a visual aid to the person showing the reduction in nicotine circulating in their bodies as they quit. This test, which was originally developed at DynaGen Inc, Cambridge Massachusetts, has been used since the mid 1990’s for such purposes. We feel strongly that the addition of NicCheck to the tools currently available will be an aid in the successful completion of a person’s smoking cessation efforts".

Donald Mossman, President
Mossman Associates, Inc.
9 Village Circle, Milford, MA 01757
508-488-6169 (P) 508-418-1397 (F)
contact@mossmanassociates.com

Innovations for Poverty Action, Teams with The Green Bank of Caraga, Using NicCheckTM to Confirm Smoking Cessation

2007-10-15T18:09:00.000-04:00

Milford, Massachusetts; 10/15/07 - Mossman Associates Inc. is pleased to announce that our NicCheckTM is being used by Innovations for Poverty Action and The Green Bank of Caraga within their CARES Campaign.
CARES, (Committed Action to Reduce and End Smoking), offered by The Green Bank of Caraga, aims at supporting smokers to quit smoking. Despite the widely known negative effects of smoking on health, smoking continues to be prevalent in many Filipino families in the absence of organized smoking cessation programs.
The CARES product allows smokers to commit to quitting within the next six months, and provides smokers with financial incentives to follow through on that commitment. Once a client opens a CARES savings account and commits to quit smoking in six months, the client will not have the access to the savings account unless he/she passes the nicotine test at the end of the six months period. The Green Bank provides deposit collection services on weekly basis, constantly reminding and encouraging the client to reduce smoking and eventually quit.
Ann Mayuga from the Innovations for Poverty Action is quoted as saying, “ Clients are encouraged to stop smoking within 6 months with the incentives provided by the CARES product. We use NicCheck to confirm that participants have truly quit smoking during this period. The NicCheck test is affordable and easy to use. We are able to reduce the hassle for the clients by having the CARES staff visit each client and conduct the test in the field.”
Donald Mossman, President of Mossman Associates Inc. notes, "We are proud to be able to contribute to a program designed to help those people trying to quit smoking. Our NicCheck product can effectively be used to monitor a person’s nicotine consumption as they reduce their dependence, as well as, to verify total cessation. The test is simple and as you can see because it is a rapid visual test it is conducive to being run in the field, lending itself to visiting nurses, spot checks and remote health stations”.
For more information contact:
Donald Mossman, President
Mossman Associates Inc.
9 Village circle
Milford, MA 01757
www.nicotinetesting.com

International Quit &Win 2006 Smoking Cessation Competition Uses NicCheck To Confirm Smoking Cessation

2006-03-01T17:55:00.000-05:00

The International Quit&Win 2006, a world wide smoking cessation competition, has chosen NicCheck once again to be the test they used to confirm smoking cessation.

Wed Mar 01 2006] Mossman Associates, Inc. announced today that the International Quit&Win 2006, a world wide smoking cessation competition, has chosen NicCheck I once again to be the test they used to confirm smoking cessation. The program which takes place every 2 years is sponsored by National Public Health Institute, KTL of Helsinki, Finland in collaboration with WHO (WHO/HQ/NPH). Quit&Win is a “Practical Collaboration For Global Tobacco Cessation” and a cost-effective way to reduce smoking among the population. The international experience shows that Quit&Win can easily be implemented in different populations and cultures.

All contestants had smoked daily for at least one year and are 18 years of age or older. The contestants are required to abstain from smoking for at least four weeks, which is verified with a urine test among the winners. The test chosen once again is NicCheck.

Quit&Win has rapidly grown in popularity as a practical international smoking cessation activity. Quit & Win began in 1994 with just 13 countries participating. Since then, the competition has taken place internationally every two years. For more information please visit http://www.quitandwin.org/portal/en/news/?id=52

Donald Mossman, President of Mossman Associates is quoted as saying “We are pleased to be involved with this important project once again and we dedicate 2006 to becoming more involved with smoking cessation projects in general. We have seen how our test can be used to enable doctors and eventually the smoker themselves to better determine the amount of Nicotine Replacement Therapy they require and also how the test can be used as a positive reinforcement tool in this difficult process. We feel strongly that the addition of NicCheck to the tools currently available will be an aid in the successful completion of anyone’s smoking cessation efforts”.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
www.mossmanassociates.com

Dutch Cancer Society Using NicCheck to Confirm Smoking Cessation

2005-06-08T17:57:00.000-04:00

Milford, Massachusetts; 6/8/05 - Mossman Associates Inc. is pleased to announce that their NicCheck is being used by The Dutch Cancer Society for their annual Quit and Win Campaign.

Quit &Win is a practical, cost-effective evidence-based smoking cessation method for population-wide public health use. The International Quit &Win Campaign, originally organized in the framework of the WHO/CINDI program, is now an international network supported by the WHO and organized by The National Public Health Institute, KTL, Helsinki Finland. Quit &Win has proven to have the capability to reach more smokers and at a lower cost than most smoking cessation interventions. It has also proven to be applicable to different cultures. The success of the Quit &Win campaigns are assessed by standardized evaluation procedures, and follow-up studies have shown that after one year, on an average 20 % of the participants have remained tobacco free.
This stop-smoking-contest is conducted worldwide every two years by The National Public Health Institute, KTL, Helsinki Finland, however in the Netherlands there will be a contest every year organized under the same rules and conditions as the parent contest and overseen by The Dutch Cancer Society.

Ingrid van den Berg from the Dutch Cancer Society is quoted as saying,
"The Dutch Cancer Society is annually organizing a Quit &Win campaign. In May 2005, 3.695 smokers quit smoking in the Netherlands. Participants could win €1.000, if they quit smoking for at least a month. In order to check if the potential winners truly quit smoking during this period, we used NicCheck to confirm if they indeed were smoke free after a month"

"We are proud to be able to contribute to a program designed to help those people trying to quit smoking, to ultimately succeed. Our NicCheck product can effectively be used to monitor a person’s nicotine consumption as they reduce their dependence, as well as, to verify total cessation", notes Donald Mossman, President of Mossman Associates Inc.

More information on the contest can be reviewed at www.quitenwin.nl or http://www.quitandwin.org/fi/content/sisallot/contact/03links?C:D=54583&C:selres=54583 for the worldwide contest.
For more information contact:
Donald Mossman
President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com

MycoDot TM Continues To Provide Rapid Serological Tuberculosis Testing In Japan

2005-02-10T17:51:00.000-05:00

Milford, Massachusetts; 2/10/05 - Mossman Associates, Inc. announced today that hundreds of thousands of their serological TB tests- MycoDot have been successfully used in the diagnosis of that disease in Japan.
MycoDot provides the Japanese the opportunity to diagnose TB within 20 minutes using a very small amount of serum or whole blood saving major amounts of time as well as establishing cost controls.

“The approval to market MycoDot in JAPAN by the Kosheio, the Japanese version of the FDA, was a major step in the acceptance of the serological testing of tuberculosis. Under the watchful eye and monitoring of the Kosheio, MycoDot continues to provide test results with high sensitivity and excellent specificity” notes Donald Mossman, President, Mossman Associates Inc. Mr. Mossman continues “we, like the majority of people working the TB space, feel that the proper identification of the disease is critical in controlling the problem. We are glad to be part of the efforts to improve upon the current TB diagnostic technology that is used in the public sector, which has not changed much in over 100 years”.

Mossman Associates, Inc. also provides reagents to other manufactures of diagnostics such as Bio-Chips, ELISA, Comb Technology, and Lateral Flow Devices.

For more information, please contact:

Donald Mossman
President
Mossman Associates Inc.
9 Village Circle.
Milford, MA 01757

USA
contact@mossmanassociates.com